Gilsenan A, Tennis P, Andrews EA, Zhou X, Coste F, Radigue C. Is it feasible to conduct a cohort study via the internet? Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2005. Nashville, TN.
Gilsenan A, Zhou X, Tennis P, Andrews EA, Coste F, Radigue C. Should we believe results obtained from an internet-based cohort study? Presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2005. Nashville, TN.
Burdett AN, Gard C, Gilsenan A, Hirji Z, Raskin J, Miller D. Prevalence and costs associated with treating depression with painful physical symptoms in a Canadian administrative services database. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2005. Nashville, TN.
Gilsenan AW, Andrews EB, Burdett AN, Martin R. Post-marketing safety surveillance studies requiring access to patients and charts: does persistence yield results? Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2005. Nashville, TN.
Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001 Dec 19;286(23):2947-55.
Gilsenan AW. Development of a minimum dataset (MDS)-based comorbidity index for a nursing home population. Poster presented at the Fourth International Society for Pharmacoeconomics and Outcomes Research Congress; 2001. [abstract] Value Health. 2001 Sep; 4(6):417-8.